Vulvar intraepithelial neoplasia: Risk factors for recurrence

Slides:

Advertisements

Similar presentations

ABO-incompatible kidney transplantation Kota Takahashi, Kazuhide Saito Transplantation Reviews Volume 27, Issue 1, Pages 1-8 (January 2013) DOI: /j.trre

Advertisements

Volume 144, Issue 1, Pages (January 2017)

Volume 349, Issue 9057, Pages (April 1997)

Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy Afshin Rashtian, M.D., Shawn Iganej,

Lifetime Increased Cancer Risk in Mice Following Exposure to Clinical Proton Beam– Generated Neutrons Leo E. Gerweck, PhD, Peigen Huang, MD, Hsiao-Ming.

Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials Gustavo Arruda Viani,

Trine Grantzau, Mette Skovhus Thomsen, Michael Væth, Jens Overgaard

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.

Volume 148, Issue 1, Pages (January 2018)

Volume 148, Issue 1, Pages (January 2018)

Volume 150, Issue 1, Pages (July 2018)

Volume 148, Issue 1, Pages (January 2018)

Are patients willing to travel for better ovarian cancer care?

Volume 148, Issue 1, Pages (January 2018)

L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L

Volume 148, Issue 1, Pages (January 2018)

Volume 145, Issue 2, Pages (May 2017)

Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008] Douglas.

Supplemental oxygen and surgical site infection: getting to the truth

Volume 144, Issue 2, Pages (February 2017)

Volume 135, Issue 1, Pages (October 2014)

M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns

Volume 151, Issue 1, Pages (October 2018)

Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei

Volume 136, Issue 2, Pages (February 2015)

Supportive care plans: Linking patient-reported outcomes to evidence-based supportive care across the cancer continuum E.E. Stevens, J.N. Bottsford-Miller,

Volume 135, Issue 2, Pages (November 2014)

Volume 152, Issue 1, Pages (January 2019)

National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence J. Chino, J.R. Foote,

Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer E.N. Prendergast,

K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani

Volume 152, Issue 1, Pages (January 2019)

Volume 152, Issue 1, Pages (January 2019)

Volume 143, Issue 2, Pages (November 2016)

The origins of multidisciplinary cancer care

Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)

Survival and failure types after radiation therapy of vulvar cancer

Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM) C. Popadiuk, A.J. Coldman,

I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M

Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,

Volume 152, Issue 1, Pages (January 2019)

Preadmission statin use improves the outcome of less severe sepsis patients - a population-based propensity score matched cohort study M.G. Lee, C.-C.

Volume 152, Issue 1, Pages (January 2019)

Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates N.A. Latif, E.M. Ko,

Volume 152, Issue 1, Pages (January 2019)

Volume 147, Issue 1, Pages (October 2017)

Cervical excisional treatment of young women: A population-based study

Volume 121, Issue 1, Pages (April 2011)

Volume 152, Issue 1, Pages (January 2019)

Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK , an AKT inhibitor, in patients with recurrent or persistent.

Volume 130, Issue 3, Pages (September 2013)

Volume 152, Issue 1, Pages (January 2019)

The complex interaction of cancer surgery, complications, and patient-reported outcomes: A single score is not enough K.M. Doll, E.L. Barber, J.T. Bensen,

Volume 142, Issue 2, Pages (August 2016)

Annika Idahl, Andrea Hermansson, Ann Lalos Gynecologic Oncology

Anne L. M. Vlek, MD, Yolanda van der Graaf, MD, PhD, Maayke A

Volume 147, Issue 3, Pages (December 2017)

Volume 152, Issue 1, Pages (January 2019)

Volume 130, Issue 1, Pages (July 2013)

Full inguinofemoral lymphadenectomy after positive sentinel inguinofemoral lymph node is associated with greater overall survival in patients with stage.

Volume 152, Issue 1, Pages (January 2019)

Treatment of Colorectal Cancer

Volume 151, Issue 1, Pages (October 2018)

Volume 152, Issue 1, Pages (January 2019)

Volume 152, Issue 1, Pages (January 2019)

Volume 152, Issue 1, Pages (January 2019)

Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma? L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,

Volume 115, Issue 1, Pages (October 2009)

Volume 152, Issue 3, Pages (March 2019)

Volume 154, Issue 1, Pages (July 2019)

Presentation transcript:

Vulvar intraepithelial neoplasia: Risk factors for recurrence W. Satmary, C.H. Holschneider, L.L. Brunette, S. Natarajan Gynecologic Oncology Volume 148, Issue 1, Pages 126-131 (January 2018) DOI: 10.1016/j.ygyno.2017.10.029 Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 1 Breakdown of study cohort patients with vulvar intraepithelial neoplasia (VIN): inclusions, exclusions and analyses. Gynecologic Oncology 2018 148, 126-131DOI: (10.1016/j.ygyno.2017.10.029) Copyright © 2017 Elsevier Inc. Terms and Conditions

Supplement 2 Cumulative incidence analysis of time to vulvar intraepithelial neoplasia (VIN) recurrence by age. VIN recurrence includes VIN 2/3 and cancer; light grey and dark grey shaded areas depict 95% confidence intervals and medium grey represents overlap. Gynecologic Oncology 2018 148, 126-131DOI: (10.1016/j.ygyno.2017.10.029) Copyright © 2017 Elsevier Inc. Terms and Conditions

Supplement 7 Cumulative incidence analysis of time to vulvar intraepithelial neoplasia (VIN) recurrence by margin status of excisional treatment. VIN recurrence includes VIN 2/3 and cancer; shaded areas represent 95% confidence intervals. Gynecologic Oncology 2018 148, 126-131DOI: (10.1016/j.ygyno.2017.10.029) Copyright © 2017 Elsevier Inc. Terms and Conditions